Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Welcome to Canbex |
Description | Rare neurological diseases - a quest for new Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders. The goal of the Canbex lead programme is to set a new standard in the treatment of spasticity, through improved |
Keywords | Canbex Therapeutics, treating spasticity, Multiple Sclerosis Society, VSN16R |
WebSite | canbex.co.uk |
Host IP | 5.77.63.117 |
Location | United Kingdom |
Site | Rank |
US$1,592
Last updated: 2022-11-11 07:48:14
canbex.co.uk has Semrush global rank of 0. canbex.co.uk has an estimated worth of US$ 1,592, based on its estimated Ads revenue. canbex.co.uk receives approximately 183 unique visitors each day. Its web server is located in United Kingdom, with IP address 5.77.63.117. According to SiteAdvisor, canbex.co.uk is safe to visit. |
Purchase/Sale Value | US$1,592 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$44 |
Yearly Ads Revenue | US$529 |
Daily Unique Visitors | 12 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
canbex.co.uk. | A | 3600 | IP: 5.77.63.117 |
canbex.co.uk. | NS | 86400 | NS Record: ns1.bdm.microsoftonline.com. |
canbex.co.uk. | NS | 86400 | NS Record: ns2.bdm.microsoftonline.com. |
canbex.co.uk. | NS | 86400 | NS Record: ns3.bdm.microsoftonline.com. |
canbex.co.uk. | NS | 86400 | NS Record: ns4.bdm.microsoftonline.com. |
canbex.co.uk. | MX | 3600 | MX Record: 0 canbex-co-uk.mail.protection.outlook.com. |
canbex.co.uk. | TXT | 3600 | TXT Record: mscid=q9Rs+5Y8R81z5FLjytrAY5pTGRGqASKAo0ZoSckrW8nLDI33F5hI5zPVVH1mb61uqw/I3b/kd9ZfVFDThjds9g== |
canbex.co.uk. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Rare neurological diseases - a quest for new treatments Canbex Therapeutics is dedicated to discovering new medicines for rare neurological diseases. Inspired by the call of patients and their families, our mission is to build on cutting-edge research by scientific pioneers to find effective new treatments for devastating disorders of the brain and nervous system. Canbex has re-focused its programs and is developing collaborations with leading laboratories, scientists and physicians. Our model aims to provide preclinical and clinical proof of concept for new approaches to diseases where few if any treatment options are currently available. The needs of patients and their families create a responsibility to make use of every available scientific advance. There is no guarantee of success, but not to act is a guarantee of failure. Canbex Therapeutics Ltd London BioScience Innovation Centre 2 Royal College Street London NW1 0NH Tel: +44(0)20 7554 5872 Email: enquiries@canbex.co.uk HOME |
HTTP/1.1 301 Moved Permanently Date: Tue, 26 Apr 2022 08:35:47 GMT Server: Apache Location: https://canbex.co.uk/ Connection: close Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Tue, 26 Apr 2022 08:35:47 GMT Server: Apache Last-Modified: Mon, 09 Mar 2020 14:47:14 GMT Accept-Ranges: bytes Content-Length: 3578 Connection: close Content-Type: text/html |